Paclitaxel + Carboplatin + Durvalumab With or Without Oleclumab for Previously Untreated Locally Recurrent Inoperable or Metastatic TNBC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to AstraZeneca
Related studies linked through entity extraction aliases.
Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Ulcerative Colitis
- Status
- TERMINATED
- Phase
- PHASE2
Study of AZD9833 Alone or in Combination in Women With Advanced Breast Cancer.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Effect of Ticagrelor vs. Placebo in the Reduction of Vaso-occlusive Crises in Pediatric Patients With Sickle Cell Disease
- Status
- TERMINATED
- Phase
- PHASE3
A Trial of Radiotherapy and Durvalumab in DLBCL and FL
- Status
- COMPLETED
- Phase
- PHASE1
Comprehensive Analysis of Gene Mutation Profile in Chinese NSCLC Patients by Next-generation Sequencing
- Status
- COMPLETED
- Phase
- N/A
Russian Severe Asthma Registry
- Status
- UNKNOWN
- Phase
- N/A
Safety and Efficacy of Dapagliflozin in Asian T2DM Subjects With Inadequate Glycemic Control on Metformin/Saxagliptin
- Status
- TERMINATED
- Phase
- PHASE3
Radiation Therapy and Durvalumab With or Without Tremelimumab in Treating Participants With Unresectable, Locally Advanced, or Metastatic Bladder Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Window of Opportunity Trial of Neoadjuvant Olaparib and Durvalumab for Triple Negative or Low ER+ Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD8233 in Healthy Male Subjects With Increased Elevated LDL-C Levels.
- Status
- COMPLETED
- Phase
- PHASE1
Lynparza Breast Cancer Clinical Experience Investigation
- Status
- COMPLETED
- Phase
- N/A
FASENRA SCEI for Long-term Use
- Status
- COMPLETED
- Phase
- N/A
Osimertinib In EGFR Mutant Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
ALEXANDRIA Study Egypt
- Status
- COMPLETED
- Phase
- N/A
Acalabrutinib, Venetoclax, and Obinutuzumab for Initial Therapy of CLL
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Biomarker-oriented Study of Durvalumab (MEDI4736) in Combination With Olaparib and Paclitaxel in Gastric Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Prospective Cohort Study of Asthma and COPD Overlap in Japanese COPD Patients Using the Diagnostic Criteria of The Japanese Respiratory Society
- Status
- COMPLETED
- Phase
- N/A
Southeast Netherlands Advanced Metastatic Breast Cancer Registry
- Status
- RECRUITING
- Phase
- N/A
A Ph 1 Study of Epanova® in Healthy Chineses
- Status
- COMPLETED
- Phase
- PHASE1